Display Settings:

Format

Send to:

Choose Destination

    Bioconjug Chem. 2005 Jul-Aug;16(4):827-36.

    Delivery of antisense oligonucleotides using cholesterol-modified sense dendrimers and cationic lipids.

    Chaltin P, Margineanu A, Marchand D, Van Aerschot A, Rozenski J, De Schryver F, Herrmann A, Müllen K, Juliano R, Fisher MH, Kang H, De Feyter S, Herdewijn P.

    Laboratory for Medicinal Chemistry, Rega Institute, Catholic University of Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium.

    Cholesterol modified mono-, di-, and tetrameric oligonucleotides were synthesized and hybridized with antisense oligonucleotides to study their incorporation in cationic liposomes together with the influence of this dendrimeric delivery system on biological activity. Electrostatic interactions seem to play the most important role during complexation with cationic lipids. This oligonucleotide formulation gives a small but significant increase in the inhibition of P-glycoprotein expression in a cellular system.

    PMID: 16029024 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read Click here to read